TVRD Tvardi Therapeutics, Inc.
P/E
--
Forward P/E
--
Price/Sales
559.61
Beta
--
Div Yield
--
Market Cap
--
Company Analysis
Latest News
🟢 Tvardi Therapeutics is trading 6% up today as biotech ETF XBI gains 2.75%
Tvardi Therapeutics is trading at $1.85, up 6.02%, in a move that appears primarily sector-driven, with biotech ETF XBI up 2.75% during regular trading. - No...
🟢 Tvardi Therapeutics is trading 6.81% up today in pre-market — catalyst remains unclear
Tvardi Therapeutics is trading at $1.86 (+6.81%) in pre-market, but the catalyst is unclear. - No clear company-specific announcement dated September 2, 2026...